Polaprezinc vs Azulene
Oral mucositis (moderate to severe) · Patients with cancer receiving radiotherapy, chemotherapy or targeted therapies
Polaprezinc led to lower oral mucositis (moderate to severe) compared with azulene; GRADE not reported.
1 finding from 1 review
- Interventions for preventing oral mucositis for patients with cancer receiving treatment 2011 · Cochrane All outcomesMedian 28 daysRR 0.43 [0.22, 0.84]1 study · 31 participantsGRADE not reported